[go: up one dir, main page]

ES2062044T3 - Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo. - Google Patents

Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.

Info

Publication number
ES2062044T3
ES2062044T3 ES89312965T ES89312965T ES2062044T3 ES 2062044 T3 ES2062044 T3 ES 2062044T3 ES 89312965 T ES89312965 T ES 89312965T ES 89312965 T ES89312965 T ES 89312965T ES 2062044 T3 ES2062044 T3 ES 2062044T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
optically active
oxoimidazolidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312965T
Other languages
English (en)
Inventor
Kimiaki Hayashi
Hitoshi Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2062044T3 publication Critical patent/ES2062044T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

DICHOS DERIVADOS DE FORMULA (I) DONDE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILICO REBAJADO DE ACUERDO AL PROCESO DESCRITO EN LA ESPECIFICACION; Y, UN DERIVADO DE ESTER ACIDO 3-ACIL-2-OXOIMIDAZOLIDINA QUE TIENE (S, R) CONFIGURACION DE FORMULA (II).
ES89312965T 1988-12-16 1989-12-12 Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo. Expired - Lifetime ES2062044T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63318745A JPH0645603B2 (ja) 1988-12-16 1988-12-16 光学活性２‐オキソイミダゾリジン誘導体の製法

Publications (1)

Publication Number Publication Date
ES2062044T3 true ES2062044T3 (es) 1994-12-16

Family

ID=18102470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312965T Expired - Lifetime ES2062044T3 (es) 1988-12-16 1989-12-12 Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.

Country Status (17)

Country Link
US (1) US5013845A (es)
EP (1) EP0373881B1 (es)
JP (1) JPH0645603B2 (es)
KR (1) KR950009364B1 (es)
CN (1) CN1032308C (es)
AT (1) ATE100817T1 (es)
AU (1) AU622959B2 (es)
CA (1) CA2004606C (es)
DE (1) DE68912745T2 (es)
DK (1) DK174701B1 (es)
ES (1) ES2062044T3 (es)
FI (1) FI97133C (es)
HK (1) HK34195A (es)
HU (1) HU203730B (es)
IE (1) IE64315B1 (es)
IL (1) IL92456A0 (es)
SG (1) SG4795G (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513292A (zh) * 2013-09-29 2015-04-15 山东新时代药业有限公司 一种雷米普利的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS6058233B2 (ja) * 1982-05-24 1985-12-19 田辺製薬株式会社 ２−オキソイミダゾリジン誘導体及びその製法
JPS6058233A (ja) * 1983-08-11 1985-04-04 ザ・アプジヨン・カンパニー 滅菌懸濁液及び溶液の保持及び混合装置

Also Published As

Publication number Publication date
DK638289A (da) 1990-06-17
AU4619589A (en) 1990-06-21
DK638289D0 (da) 1989-12-15
DE68912745T2 (de) 1994-05-11
DK174701B1 (da) 2003-09-29
JPH02164869A (ja) 1990-06-25
CN1032308C (zh) 1996-07-17
ATE100817T1 (de) 1994-02-15
SG4795G (en) 1995-06-16
IL92456A0 (en) 1990-08-31
EP0373881A2 (en) 1990-06-20
DE68912745D1 (de) 1994-03-10
FI895795A0 (fi) 1989-12-04
FI97133C (fi) 1996-10-25
HU896640D0 (en) 1990-02-28
AU622959B2 (en) 1992-04-30
CN1043705A (zh) 1990-07-11
IE64315B1 (en) 1995-07-26
CA2004606C (en) 1997-01-07
CA2004606A1 (en) 1990-06-16
EP0373881B1 (en) 1994-01-26
HUT52064A (en) 1990-06-28
KR950009364B1 (ko) 1995-08-21
KR900009603A (ko) 1990-07-05
FI97133B (fi) 1996-07-15
IE894004L (en) 1990-06-16
EP0373881A3 (en) 1990-08-16
JPH0645603B2 (ja) 1994-06-15
US5013845A (en) 1991-05-07
HK34195A (en) 1995-03-17
HU203730B (en) 1991-09-30

Similar Documents

Publication Publication Date Title
FI893467L (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ES8604544A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES481633A1 (es) Un procedimiento de preparacion de derivados de 4-fenil-2- tiazolil-oxamato.
ES8400079A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
MX162518A (es) Procedimiento para preparar derivados de hidroxido de aminopiridinio
ES2062044T3 (es) Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.
ES8601098A1 (es) Procedimiento para la obtencion de monoesteres de acido tartarico opticamente puros de alcanolaminas opticamente activas
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
BG41129A3 (en) Method for preparing acetamide derivatives
ES2059767T3 (es) Derivado de 1,4-dihidropiridina.
BG34033A3 (en) A method of obtaining optically active, at a given time substituted 2- amino- 2- phenyl acetic acid
ES2153124T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ES2084725T3 (es) Nuevos derivados de ciclobutano.
ES2080898T3 (es) Procedimiento para la preparacion de una ciclobutanona opticamente activa, un producto intermedio en la sintesis de un nucleosido de ciclobutano opticamente activo.
ES2003629A6 (es) Procedimiento para preparar nuevos derivados de acidos fenilaceticos
NO851206L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 1,4-dihydropyridiner
DK536386A (da) 5- eller 6-substituerede beta-carbolin-3-carboxylsyreestere, fremgangsmaade til fremstilling heraf samt deres anvendelse
ES8504193A1 (es) Un procedimiento de preparacion de hexahidro-indolo-naftiridinas
DK159432C (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
ES8506756A1 (es) Procedimiento para preparar derivados de afidicolina.
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
SU1363772A1 (ru) Способ получения изопропил-n-фенилкарбамата
ES2073606T3 (es) Procedimiento para la preparacion de derivados de acido beta-resorcilico.
ES465207A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolo-benzoicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 373881

Country of ref document: ES